End-to-End Integrated Drug Discovery

Home  Brochures

Introduction

At PI Health Sciences, we unite artificial intelligence with deep scientific insights in a fully integrated discovery ecosystem. Our AI-powered workflows accelerate every stage of discovery, from target validation to clinical candidate selection, enabling faster, data-driven innovation.

Explore our core focus areas:

  • AI & Medicinal Chemistry: AI-guided design of novel lead candidates , including PROTACs, molecular glues, and peptides.
  • AI-Driven Design: Leverage generative AI for de novo molecule design and virtual screening of ultra-large libraries (>10B compounds).
  • Target Biology: Comprehensive validation of therapeutic targets and pathway biology.
  • DMPK: In vitro ADME and in vivo PK studies to optimize drug-like properties.

Discover how our unified platform and strategic, IP-safe partnerships can accelerate your program.

Download the complete brochure to see how we build your next clinical candidate.

https://pihealthsciences.com/wp-content/uploads/2025/10/Integrated-Drug-Discovery.pdf

    Latest Insights